SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001338095-17-000023
Filing Date
2017-05-11
Accepted
2017-05-11 13:27:19
Documents
17
Period of Report
2017-05-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrx8-kapril2017mor_05112017.htm 8-K 35560
2 EXHIBIT 99.1 di423aprilmor.htm EX-99.1 4396
3 di423aprilmor001.jpg GRAPHIC 93127
4 di423aprilmor002.jpg GRAPHIC 25833
5 di423aprilmor003.jpg GRAPHIC 14380
6 di423aprilmor004.jpg GRAPHIC 121383
7 di423aprilmor005.jpg GRAPHIC 217091
8 di423aprilmor006.jpg GRAPHIC 141267
9 di423aprilmor007.jpg GRAPHIC 78866
10 di423aprilmor008.jpg GRAPHIC 121505
11 di423aprilmor009.jpg GRAPHIC 135069
12 di423aprilmor010.jpg GRAPHIC 161871
13 di423aprilmor011.jpg GRAPHIC 75512
14 di423aprilmor012.jpg GRAPHIC 83658
15 di423aprilmor013.jpg GRAPHIC 158529
16 di423aprilmor014.jpg GRAPHIC 59290
17 di423aprilmor015.jpg GRAPHIC 117636
  Complete submission text file 0001338095-17-000023.txt   2218489
Mailing Address P.O. BOX 400 JAMISON PA 18929
Business Address P.O. BOX 400 JAMISON PA 18929 6095538887
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 17833475
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences